Filing Details
- Accession Number:
- 0001104659-22-011445
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-03 17:58:36
- Reporting Period:
- 2022-02-01
- Accepted Time:
- 2022-02-03 17:58:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1657312 | Verona Pharma Plc | VRNA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1847538 | Lisa Deschamps | 3 More London Riverside London X0 SE1 2RE | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2022-02-01 | 11,664 | $0.78 | 70,320 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units.
- The price reported represents the sale price of the Issuer's ADSs divided by eight (8).
- Consists of 70,320 Ordinary Shares underlying 8,790 ADSs.